RGRana Ayad Ghaleb

Rana Ayad Ghaleb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rana Ayad Ghaleb has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Ali M. Jaafar Abdulsahib

    Department of Pharmacology, College of Pharmacy, University of Alameed, Karbala, Iraq

    1 shared publication
  • Ali N. Wannas

    Department of Pharmaceutics, Faculty of Pharmacy, University of Kufa, Al-Najaf, Iraq

    1 shared publication
  • Nisreen Jalal Mohammed

    Department Pharmacology, College of Medicine, University of Babylon, Hillah, Iraq

    1 shared publication
  • Sabah H Enayah

    Department of Biology, College of Science, University of Thi-Qar, Nasiriyah, Iraq

    1 shared publication
  • Sarah K Obayes

    Department of Pharmacology and Toxicology, College of Pharmacy, University of Kufa, Kufa, Iraq

    1 shared publication
  • Sarah K. Obayes

    Department of pharmacology and toxicology, Faculty of Pharmacy, University of Kufa, Al-Najaf, Iraq

    1 shared publication

Latest Publications

  • Open Access

    The Combination Effect of Chemotherapy Drug with Febuxostat and Curcumin on Colon Cancer Cell line (LS174T)

    by Ali M. Jaafar Abdulsahib, Rana Ayad Ghaleb, Nisreen Jalal Mohammed

    Background: Colorectal cancers are the 3rd highest commonly discovered form of cancer worldwide. The outcomes of various studies have revealed that cancer cells growth has been affected in response to treatment. In this study, the in vitro cytotoxic effects of different drug combinations [5-fluorouracil (5-FU), curcumin, and febuxostat] were measured by crystal violet method. The results showed significant anticancer activity on LS174T colorectal cancer cell line at different combinations. Objective: This study aimed to assess the cytotoxic effect of different combinations of 5-FU, curcumin, and febuxostat on colorectal cancer LS174 cell line. Materials and Methods: For 24 h, the human colon cancer cell line LS174T was given a variety of doses of combinations of 5-FU, febuxostat, and curcumin. Crystal violet assay was used to assess the cytotoxicity of the combined agents extract against colon cancer cells. Results: 5-FU, curcumin, and febuxostat when used in different combinations concentrations, showed respectable anticancer effect on colorectal cancer LS174T cell line. Conclusion: The current study indicated that the good anticancer effects of combined agents when used to treat colorectal cancer.

  • Open Access

    Detection of new single nucleotide polymorphisms in plasma cells carcinoma (myeloma) by polymerase chain reaction–single strand conformation polymorphism and sequencing technical methods

    by Sarah K Obayes, Sabah H Enayah, Shaimaa A Al-Oubaidy, Rana A Ghaleb

    Background: MicroRNA (miRNA) is a short, single-stranded, non-coding sequence of RNA that does not translate into proteins. Because of their ability to control gene expression, recent studies have shown that these short, non-coding sequences play an important role in cancer. So that, detection the polymorphisms or variants in miRNA genes may help to identify their correlation to cancer susceptibility. Objectives: Study the polymorphisms in miRNA genes or variants miRNA genes and their correlation with myeloma disease. Materials and Methods: Twenty samples were collected from people who visited Marjan Hospital in Province of Babylon, Iraq, from February to July 2022. In addition, 20 samples from healthy people were collected as control. Genotyping of miRNA was accomplished using the polymorphism techniques of polymerase chain reaction and single strand conformation polymorphism (SSCP). DNA sequencing was also applied to categorize all the ranges of SSCP models detected using only gel imaging. Results: The genotypes obtained in this experiment verified that several single nucleotide polymorphisms were obtained between 5-band and 6-band miRNA National center for biotechnology information Primer3 plus reference. Conclusion: The results explain that the miRNA gene polymorphisms may have correlation with the susceptibility to myeloma disease.


  • Open Access

    Lipid nanoparticles as theranostic vesicle

    by Ali Wannas, Sarah K. Obayes, Zahraa Fathi Sharba, Rana A. Ghaleb

    Lipid nanoparticles (LNP) are the most well-studied first approved nanomedicine for drug delivery of therapeutic and vaccine formulation products. However, their nature is under constant investigation especially their liquid crystal state which leads to their complex biological behavior. LNPs are generally regarded as safe (GRAS) and suitable for ameliorating the toxicity and/or improving the pharmacokinetics of newly approved biomaterials with promising functionality and effects. During the past decade, many promising theranostic applications for LNPs have emerged resulting in huge potential for them in this field. Although there is progress in theranostic application, the gap between the bench and clinical application is undeniable, and that must be addressed to exploit the benefits of these nanomedicines for society.